Weekly Watchlist and Review 9/4/23

Weekly Watchlist and Review

Traders, Investors, and Market Enthusiasts, dive into our newest edition of the Weekend Watchlist and Review. First of all happy Labor Day! At ALERTSANDNEWS.COM, the alerts have been on another level, we’re seeing some great runners daily. Here’s a brief recap of some of our recent star alerts:

VFS was a standout, first getting your attention at 18.84 and then rocketing to the low 90s, a monster move by any measure. But let’s not forget ICCT. We flagged it in pre market as a potential squeeze candidate, and did it ever squeeze… soaring over 1000% after breaking its trend. Between VFS, ICCT, and other huge winners like GDC HE LQ, AXLA GSAT THSA DBGI NAOV TIO ACER ADTX SQL and EDBL, it’s been a stellar week. Winning plays every single day!

At ALERTSANDNEWS.COM, being consistent and calibrated is our hallmark. With alerts spanning from momentum, overnights, swings, options, dividend stocks… catalysts to entires/targets/stops daily! Making sure doing your own DD and learning is most important! But if you’re in pursuit of exceptional alerts and insights. Browse through highlights of our best alerts from the past week on the screenshots, some monsters last week! And remember, the code LABOR20 gets you a 20% discount during signup. Join us and take your trading to the next level!

Let’s start what to eye tomorrow, and the news over the weekend.

Heres the Gappers from Friday. Seeing some headlines both on Friday and over the weekend to monitor. Lets take a look here. 

HSDT: No headline on Friday but Wednesday evening we saw some insider buying. 

HELIUS MEDICAL TECHNOLOGIES, INC.: ANDREEFF DANE (Director, President and CEO, 10%+) Buys 10,078 @ Avg Price: $7.00 (Form4)

Trend to monitor here. Targets as well if it breaks. Keep it on the radar tomorrow. 

Let’s go over the weekend headlines 

  • SGEN GMAB Seagen and Genmab Announce TIVDAK® (tisotumab vedotin-tftv) Improved Overall Survival in Patients With Recurrent or Metastatic Cervical Cancer Compared With Chemotherapy Alone- Met its Primary Endpoint of Improved Overall Survival in Patients.
  • RACE Ferrari N.V.: Periodic Report on the Buyback Program
  • Verisk Estimates Industry Insured Losses from Hurricane Idalia Will Range from USD 2.5 Billion to USD 4 Billion

  • MIXT MiX Telematics Announces DVS & FORS Partnership with Parksafe Group in the UK

  • IGMS Medivir reports promising interim data, including a first complete response in phase 1b/2a HCC study with fostrox in combination with Lenvim

  • Changpeng Zhao Says Binance Is ‘Much Stronger’ And ‘Way Ahead’ In Regulatory Compliance

  • TUYA Tuya Smart and Amazon Web Services Collaborate to Establish an IoT Security Lab

  • ALB Albemarle Confirmed Non-binding Agreement To Acquire Liontown For US$4.32B On An Equity Value Basis

  • President Biden Said He Was Disappointed That Chinese President Xi Jinping Was Not Attending The Summit Of G20 Leaders In India-Reuters

  • RLYB Rallybio Presents Phase 1 Single Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5

  • AMC Taylor Swift’s ‘Era’s Tour’ Rakes In $26 Million In Pre-sales, Shattering AMC Records

  • AAPL MSFT Financial Times Reported Apple And Microsoft Have Argued Some Of Their Flagship Services Are Insufficiently Popular To Be Designated Gatekeepers Under New EU Legislation
  • China Commerce Minister Wang met with Italy’s Finance Minister Tajani – Mofcom.

  • No documents are expected to be signed after Putin and Turkey’s President Erdogan’s meeting – Ria

  • Credit Suisse posted $4 billion loss in 2Q – Sonntagszeitung

  • Elon Musk Reveals Video Views On X Have ‘Roughly Doubled’ In Just A Year As CEO Yaccarino Cheers Milestone

     
  • NVDA Nvidia’s Jensen Huang Eyes India’s AI Future In High-Level Meeting With Prime Minister Modi

  • AAPL DigiTimes Reported Earlier Monday, Apple Considering Release Of A Low-Cost MacBook Series To Compete With Chromebook Models

 
 

News Coming:

By staying informed about the FDA decisions and other news. Investors, healthcare professionals, and patients can gauge the potential impact on the pharmaceutical industry, stock market, and patient care. These decisions can influence the market value of pharmaceutical companies. Let’s look at the news coming: 

Stock Ticker Company NameDecision DetailsEstimated Decision Date
BLRX

BioLineRx Ltd.

FDA decision on proposed use of APHEXDA in stem cell mobilization for autologous transplantation in multiple myeloma patients

9/9/2023
ALNYAlnylam Pharmaceuticals Inc.FDA panel to review Onpattro for the expanded use in treating cardiomyopathy of transthyretin-mediated (ATTR) amyloidosis9/13/2023
HALOHalozyme Therapeutics, Inc.

FDA decision on Subcutaneous Tecentriq for patients with advanced non-small cell lung cancer

9/15/2023
BCLI

Brainstorm Cell Therapeutics Inc

FDA panel to review NurOwn for the treatment of amyotrophic lateral sclerosis9/27/2023
OCUPNyxol (NDA)FDA decision on Nyxol for the treatment of pharmacologically induced mydriasis9/28/2023
AMGNAmgen Inc.FDA panel to discuss conversion of accelerated approval on LUMAKRAS for adults with previously treated locally advanced or metastatic KRAS G12C-mutated non-small cell lung cancer to full approva10/05/2023
ARDX

Ardelyx, Inc

FDA decision on XPHOZAH for the control of serum phosphorus in adult patients with chronic kidney disease on dialysis who have had an inadequate response or intolerance to a phosphate binder therapy.10/17/2023

Let’s look at some oversold and/or highly shorted stocks. 

Understanding oversold and highly shorted stocks is crucial for traders and investors as it prepares them to seize potential opportunities. Oversold stocks might represent a bargain if they are undervalued due to excessive selling. Highly shorted stocks are poised for what’s called a short squeeze. A rapid price increase that can occur when short sellers scramble to cover their positions. By staying informed, investors can be better prepared to navigate the market.

AAMC: Back for a second week on our watchlist. Man, this stock has been on a nosedive for some time, no real bounce to speak of. The daily MACD’s starting to come together and the RSI is screaming oversold. The short float isn’t crazy, around 10%. But that’s still worth noting. Last time we hit these mid-8s, it bounced back nice. Definitely one to keep an eye on for the next few weeks.

AVXL: Here’s another one worth watching. Solid support level being tested, and every time it’s bounced off this line for the past year, it’s popped up nicely. RSI is way low, and MACD is converging for a bull cross. Short float is around 20%, so that’s something to keep in mind. This one’s on our radar to see if that trend support holds up again.

NCNC: Man, the IPO market’s been wild, hasn’t it? This one’s a recent IPO and let me tell you, it’s been dropping like a stone. Seriously oversold right now. The big question is, can it catch a second wind with all this IPO buzz we’ve been seeing? Worth keeping a close eye on this one, either as a sympathy play or in case the IPO wave decides to roll back in. Keep it on your radar

BTAI: Back for Week 2 on the list. This stock’s been kicked around big time. According to one source short float has move down a little bit from last week to around 34% of the float. If those shorts start sweating, we might see some fireworks. It’s deep in oversold territory and chock full of shorts—sounds like squeeze material to me. Don’t sleep on this one; keep it locked in your sights.

Oversold beat up stocks to eye,

DBGI, RCRT, CRKN, IDEX, AMC, TLSI, JBLU, DMS, OTRK, BLNK, FFIE

Upcoming Earnings:

Economic Calendar and Futures.

TIME (ET)REPORTPERIODACTUALMEDIAN FORECASTPREVIOUS
MONDAY, SEPT. 4     
 Labor Day holiday    
TUESDAY, SEPT. 5     
10:00 amFactory ordersJuly -2.3%2.3%
WEDNESDAY, SEPT. 6     
8:30 amU.S. trade deficitJuly -$68.3B-$65.5B
9:45 amS&P final U.S. services PMIAug.  51.0
10:00 amISM servicesAug. 52.7%52.7%
2:00 pmFed Beige Book    
THURSDAY, SEPT. 7     
8:30 amInitial jobless claimsSept. 2 230,000228,000
8:30 amU.S. productivity (revision)Q2 3.4%3.7%
8:30 amUnit-labor costs (revision)Q2 1.9%1.6%
9:00 amPhiladelphia Fed President Patrick Harker speaks    
11:45 amChicago Fed President Austan Goolsbee speaks    
3:30 pmNew York Fed President John Williams speaks    
3:45 pmAtlanta Fed President Raphael Bostic speaks    
7 pmAtlanta Fed President Raphael Bostic speaks    
7:05 pmDallas Fed President Lorie Logan speaks    
FRIDAY, SEPT. 8     
10:00 amWholesale inventoriesJuly -0.1%-0.5%
11:00 amSan Francisco Fed President Mary Daly speaks    
3:00 pmConsumer creditJuly $19.5B$17.9B

Coming up this week, we’ve got a bunch of important economic updates that’ll catch the market’s attention. Starting off with Tuesday, Sept 5th, we’ll see factory orders for July. Then, get ready for Wednesday. We’ve got updates on the U.S. trade deficit, the final U.S. services PMI, and ISM services. Also, the Fed’s Beige Book is set to be released at 2 PM EDT. Thursday will feature initial jobless claims and a lineup of Fed big names—Harkin, Goolsbee, Williams, and Bostic—all set to speak. To close out the week on Friday, we’ve got wholesale inventories on deck and Fed President Daly speaking at 11 AM. Don’t forget, consumer credit data will be out at 3 PM as well. Busy week, so keep your eyes peeled.

As of 6:08 PM EDT, market futures are  green, For more targeted insights and timely alerts, make sure to check us out at alertsandnews.com Don’t forget to use the promo code Labor20 for 20% discount on all our packages. Getting the team the first mover advantage. Get informed first with your command center for the markets. Don’t let the next big opportunity pass you by! Sign up today!

DISCLAIMER

The forum, blog, watchlist and chatrooms on the Site are comprised of customers and members (including, without limitation, moderators who are in the employ of Alerts and News) posting content and information. All such information and content is for informational purposes only and does not constitute advice or a recommendation by Alerts and News to enter into any securities transactions or engage in any of the financial strategies reflected on or suggested in forum, blog, watchlist and chatrooms (whether such data, content or information is posted by Alerts and News or otherwise). Customers and members may write about securities in which they have a financial or other interest, and performance data reflecting other customer’s or member’s holdings may include information about securities not held by Alerts and News or its directors, officers, shareholders, employees, agents or affiliates. As such, Alerts and News is not responsible for the accuracy of data, content or information or any performance data in any forum, blog, watchlist and chatrooms; and the accuracy of data, content or information or any performance data are not guaranteed, may not be current and should not be relied upon. Nothing in any forum, blog, watchlist and chatrooms is intended as, nor should you rely on it as, investment advice provided by Alerts and News or its directors, officers, shareholders, employees, agents or affiliates. AlertsAndNews receives cash compensation for referring potential clients to Benzinga LLC via advertisements placed on their website. AlertsAndNews’s opinions are their own.

Take your trading to the next step!

Try a trial – for less than a cup of coffee

Shopping Cart
Scroll to Top